Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Determinants of cancer response to immunotherapy

Determinants of cancer response to immunotherapy

US Patent 11332530 · Granted May 17, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Neoantigens and uses thereof for treating cancer2025
Tumor mutational load2022
Determinants of cancer response to immunotherapy by PD-1 blockade2021
Screening assays for cancer chemopreventative agents1999